Nonetheless, our study mainly focused on the role of METTL3‐mediated m6A modification in sorafenib resistance under intratumoral environment‐like conditions and identified that the METTL3/FOXO3 axis is involved in acquired sorafenib resistance in HCC. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.